Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rong Qiao, Feifei Di, Jun Wang, Yujie Wei, Yanman Zhang, Tian Xu, Yue Wang, Wanjian Gu, Baohui Han & Rongxi Yang. (2020) The Association Between RAPSN Methylation in Peripheral Blood and Early Stage Lung Cancer Detected in Case–Control Cohort. Cancer Management and Research 12, pages 11063-11075.
Read now
Read now
Sara Chiker, Vincent Pennaneach, Damarys Loew, Florent Dingli, Denis Biard, Fabrice P Cordelières, Simon Gemble, Sophie Vacher, Ivan Bieche, Janet Hall & Marie Fernet. (2015) Cdk5 promotes DNA replication stress checkpoint activation through RPA-32 phosphorylation, and impacts on metastasis free survival in breast cancer patients. Cell Cycle 14:19, pages 3066-3078.
Read now
Read now
Nicola Amodio, Dina Bellizzi, Marzia Leotta, Lavinia Raimondi, Lavinia Biamonte, Patrizia D’Aquila, Maria Teresa Di Martino, Teresa Calimeri, Marco Rossi, Marta Lionetti, Emanuela Leone, Giuseppe Passarino, Antonino Neri, Antonio Giordano, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2013) miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells. Cell Cycle 12:23, pages 3650-3662.
Read now
Read now
Articles from other publishers (29)
Kumar Nikhil & Kavita Shah. (2023) CDK5: an oncogene or an anti-oncogene: location location location. Molecular Cancer 22:1.
Crossref
Crossref
Mitra Zabihi, Ramin Lotfi, Amir-Mohammad Yousefi & Davood Bashash. (2022) Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities. Journal of Cancer Research and Clinical Oncology 149:4, pages 1585-1606.
Crossref
Crossref
Miriana Di Stefano, Salvatore Galati, Gabriella Ortore, Isabella Caligiuri, Flavio Rizzolio, Costanza Ceni, Simone Bertini, Giulia Bononi, Carlotta Granchi, Marco Macchia, Giulio Poli & Tiziano Tuccinardi. (2022) Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors. International Journal of Molecular Sciences 23:18, pages 10653.
Crossref
Crossref
Shridhar Veeresh Pattar, Shakeel Ahamed Adhoni, Chandrappa Mukappa Kamanavalli & Suresh Sadashiv Kumbar. (2020) In silico molecular docking studies and MM/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer. Beni-Suef University Journal of Basic and Applied Sciences 9:1.
Crossref
Crossref
Brilliant N. Marak, Jayanta Dowarah, Laldingluaia Khiangte & Ved Prakash Singh. (2020) A comprehensive insight on the recent development of Cyclic Dependent Kinase inhibitors as anticancer agents. European Journal of Medicinal Chemistry 203, pages 112571.
Crossref
Crossref
Jordan L Kohlmeyer, David J Gordon, Munir R Tanas, Varun Monga, Rebecca D Dodd & Dawn E Quelle. (2020) CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets. International Journal of Molecular Sciences 21:8, pages 3018.
Crossref
Crossref
Hailong Tang, Li Xu, Xi Cen, Li Yang, Juan Feng, Guang Li, Huafeng Zhu, Shan Gao, Yan Yu, Yaping Zhao, Zhiqiang Tian, Liping Hou, Shuchun Yu & Guangxun Gao. (2020) CDK5 inhibition in�vitro and in vivo induces cell death in�myeloma and overcomes the obstacle of bortezomib resistance. International Journal of Molecular Medicine.
Crossref
Crossref
Samanta Sharma & Piotr Sicinski. (2020) A kinase of many talents: non-neuronal functions of CDK5 in development and disease. Open Biology 10:1, pages 190287.
Crossref
Crossref
Chia-Yi Su, Ruei-Liang Yan, Wen-Hsin Hsu, Ching-Tung Chu, Hsuan-Chia Chang, Chien-Chen Lai, Hui-Ping Hsu & Hong-Chen Chen. (2019) Phosphorylation of adducin-1 by cyclin-dependent kinase 5 is important for epidermal growth factor-induced cell migration. Scientific Reports 9:1.
Crossref
Crossref
Yun Dai, Fengyan Jin, Wei Wu & Shaji K. Kumar. (2019) Cell cycle regulation and hematologic malignancies. Blood Science 1:1, pages 34-43.
Crossref
Crossref
Elena Kapora, Shujun Feng, Wei Liu, Indira Sakhautdinova, Bo Gao & Wenhua Tan. (2019) MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer. Bioscience Reports 39:7.
Crossref
Crossref
Magdalena Bachmann, Roberto Costa, Roberta Peruzzo, Elena Prosdocimi, Vanessa Checchetto & Luigi Leanza. (2018) Targeting Mitochondrial Ion Channels to Fight Cancer. International Journal of Molecular Sciences 19:7, pages 2060.
Crossref
Crossref
Saranya NavaneethaKrishnan, Jesusa L. Rosales & Ki-Young Lee. (2018) Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore. Oncogene 37:13, pages 1788-1804.
Crossref
Crossref
Jimma Likisa Lenjisa, Solomon Tadesse, Nishat Zareen Khair, Malika Kumarasiri, Mingfeng Yu, Hugo Albrecht, Robert Milne & Shudong Wang. (2017) CDK5 in oncology: recent advances and future prospects. Future Medicinal Chemistry 9:16, pages 1939-1962.
Crossref
Crossref
Floriana Maria Farina, Alessandra Inguscio, Paolo Kunderfranco, Alice Cortesi, Leonardo Elia & Manuela Quintavalle. (2017) MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines. Cell Death & Disease 8:6, pages e2890-e2890.
Crossref
Crossref
Linlin Ding, Yaodong Shen, Jing Ni, Yiqing Ou, Yangyu Ou & Hong Liu. (2017) EphA4 promotes cell proliferation and cell adhesion–mediated drug resistance via the AKT pathway in multiple myeloma. Tumor Biology 39:3, pages 101042831769429.
Crossref
Crossref
Hanley N. Abramson. (2016) Kinase inhibitors as potential agents in the treatment of multiple myeloma. Oncotarget 7:49, pages 81926-81968.
Crossref
Crossref
Pao-Hsuan Huang, Mei-Chih Chen, Yu-Ting Peng, Wei-Hsiang Kao, Chih-Hsiang Chang, Yun-Chi Wang, Chih-Ho Lai, Jer-Tsong Hsieh, Jo-Hsin Wang, Yueh-Tsung Lee, Eugene Lin, Chia-Herng Yue, Hsin-Yi Wang, Shuen-Chi You & Ho Lin. (2016) Cdk5 Directly Targets Nuclear p21CIP1 and Promotes Cancer Cell Growth. Cancer Research 76:23, pages 6888-6900.
Crossref
Crossref
Karine Pozo & James A. Bibb. (2016) The Emerging Role of Cdk5 in Cancer. Trends in Cancer 2:10, pages 606-618.
Crossref
Crossref
Jahangir Abdi, Hou Jian & Hong Chang. (2016) Role of micro-RNAs in drug resistance of multiple myeloma. Oncotarget 7:37, pages 60723-60735.
Crossref
Crossref
Robert RoskoskiJr.Jr.. (2016) Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs. Pharmacological Research 107, pages 249-275.
Crossref
Crossref
Kanglai Wei, Zhihua Ye, Zuyun Li, Yiwu Dang, Xin Chen, Na Huang, Chongxi Bao, Tingqing Gan, Lihua Yang & Gang Chen. (2016) An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker. World Journal of Surgical Oncology 14:1.
Crossref
Crossref
Ruan Yushan, Chen Wenjie, Huang Suning, Dang Yiwu, Zhong Tengfei, Wickramaarachchi Mihiranganee Madushi, Luo Feifei, Zhang Changwen, Wen Xin, Gopaul Roodrajeetsing, Li Zuyun & Chen Gang. (2015) Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study. World Journal of Surgical Oncology 13:1.
Crossref
Crossref
Savita Bisht, Jens Nolting, Ute Schütte, Jens Haarmann, Prashi Jain, Dhruv Shah, Peter Brossart, Patrick Flaherty & Georg Feldmann. (2015) Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread—Identification of a Promising Novel therapeutic target. Translational Oncology 8:4, pages 295-307.
Crossref
Crossref
Shu Zhang, Zhen Lu, Weiqun Mao, Ahmed A. Ahmed, Hailing Yang, Jinhua Zhou, Nicholas Jennings, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Roberto Miranda, Wei Qiao, Veera Baladandayuthapani, Zongfang Li, Anil K. Sood, Jinsong Liu, Xiao-Feng Le & Robert C. Bast. (2015) CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. PLOS ONE 10:7, pages e0131833.
Crossref
Crossref
Julia Lindqvist, Susumu Y. Imanishi, Elin Torvaldson, Marjo Malinen, Mika Remes, Fanny Örn, Jorma J. Palvimo & John E. Eriksson. (2015) Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells. Molecular Biology of the Cell 26:11, pages 1971-1984.
Crossref
Crossref
Marion Peyressatre, Camille Prével, Morgan Pellerano & May Morris. (2015) Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors. Cancers 7:1, pages 179-237.
Crossref
Crossref
Brajendra K. Tripathi, Xiaolan Qian, Philipp Mertins, Dunrui Wang, Alex G. Papageorge, Steven A. Carr & Douglas R. Lowy. (2014) CDK5 is a major regulator of the tumor suppressor DLC1. Journal of Cell Biology 207:5, pages 627-642.
Crossref
Crossref
Camille Prével, Laetitia Kurzawa, Thi Nhu Ngoc Van & May C. Morris. (2014) Fluorescent biosensors for drug discovery new tools for old targets – Screening for inhibitors of cyclin-dependent kinases. European Journal of Medicinal Chemistry 88, pages 74-88.
Crossref
Crossref